Are you looking to discover Mounjaro, the groundbreaking weight loss treatment, now available in the UK. At My London Pharmacy, we're your trusted source when you're ready to take the next step in your weight loss journey. Mounjaro, an innovative GLP-1 agonist, has garnered attention for its remarkable results in clinical studies for both diabetes management and weight loss.

Update 8th September 2023:NICE committee recommends Mounjaro as new treatment option for people with type 2 diabetes

Buy Mounjaro in the UK

When Mounjaro becomes available in the UK, you'll be able to conveniently request it online from our UK-registered online pharmacy. This prescription weight loss treatment is manufactured by Eli Lilly, a reputable pharmaceutical company.

Understanding Mounjaro for Weight Loss

Mounjaro is tailored for individuals with a body mass index (BMI) over 30 or those with a BMI over 27 who have weight-related medical issues such as type 2 diabetes, high cholesterol, obstructive sleep apnoea, or high blood pressure.

How Mounjaro Works

Mounjaro features tirzepatide, an active ingredient that belongs to the GLP-1 agonist drug class. GLP-1 is a hormone that helps regulate hunger, naturally released by the intestines after meals. Mounjaro mirrors this hormone's action, curbing appetite and creating a feeling of fullness. This can lead to reduced calorie intake and significant weight loss. Combining Mounjaro with a calorie-controlled diet can enhance these effects.

Is Mounjaro Right for You?

Consider Mounjaro for weight loss if you've previously attempted weight reduction through exercise and diet without success. While Mounjaro is not currently available in the UK, alternatives like Saxenda, Wegovy, and Ozempic, which are also GLP-1 agonists, can be explored.

Effectiveness of Mounjaro

Using Mounjaro pens to control appetite typically results in losing around 15-20% of your initial body weight upon completing the treatment.

Dosage and Administration

Mounjaro is administered weekly via an injectable pen, usually in the upper arm, upper thigh, or abdomen. The treatment begins with a recommended starting dosage of 2.5 mg weekly for four weeks. After this period, doses are incrementally increased by 2.5 mg, up to a maximum of 15 mg once weekly.

Exploring Alternatives

While Mounjaro presents an innovative approach to weight loss, it's essential to remember that adopting a healthy diet and increasing physical activity are the preferred and safest ways to lose weight. The NHS offers a 12-week weight loss plan, providing guidance on exercise and dietary improvements.

In the UK, there are alternative GLP-1 drugs, such as Wegovy, Saxenda, and Ozempic. For those who prefer non-injectable options, traditional weight loss pills like Orlistat are available.

Summary

• Mechanism: Appetite suppression
• Effectiveness: 15-20% average body weight loss
• Common Side Effects: Fatigue, dizziness, insomnia, digestive issues
• Cautions: Inappropriate for individuals with certain medical conditions; potential drug interactions

When considering Mounjaro for weight loss, consult with your healthcare provider for personalised guidance.

References:

1. National Institute for Health and Care Excellence (NICE) Guidelines.
2. Clinical Trials and Studies on Tirzepatide (Mounjaro).
3. UK Diabetes Organisations and Resources.
4. Tirzepatide: A Novel GLP-1 Agonist for Type 2 Diabetes and Beyond (Clinical Study).
5. Tirzepatide for Type 2 Diabetes Mellitus: A Comprehensive Review (Clinical Study).
6. Eli Lilly Official Website.
7. NICE Recommends Mounjaro (Tirzepatide) for Type 2 Diabetes